CNB Bank boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,962 shares of the medical research company’s stock after purchasing an additional 263 shares during the period. CNB Bank’s holdings in Charles […]